Ideaya Biosciences Inc (IDYA)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Yujiro S. Hata
Employees:
80
7000 SHORELINE COURT, SUITE 350, SOUTH SAN FRANCISCO, CA 94080
650-443-6209

IDEAYA Biosciences, Inc. focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions.

Data derived from most recent annual or quarterly report
Market Cap 1.823 Billion Shares Outstanding57.559 Million Avg 30-day Volume 735.78 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0.04
Price to Revenue29.2812 Debt to Equity0.0 EBITDA-87.704 Million
Price to Book Value2.6353 Operating Margin-187.7749 Enterprise Value811.809 Million
Current Ratio19.805 EPS Growth0.145 Quick Ratio19.492
1 Yr BETA 0.7144 52-week High/Low 32.33 / 13.29 Profit Margin-164.253
Operating Cash Flow Growth-58.2776 Free Cash Flow to Firm (FCFF) TTM -105.326 Million Free Cash Flow to Equity (FCFE) TTM-61.368 Million
Altman Z-Score30.4441
View SEC Filings from IDYA instead.

View recent insider trading info

Ideaya Biosciences Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding IDYA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IDYA

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-11-07 by THRONE JASON
  • 4: filed on 2023-09-14 by THRONE JASON
  • 4: filed on 2023-09-06 by THRONE JASON
  • 4: filed on 2023-09-06 by RUIZ BRISENO ANDRES
  • 4: filed on 2023-08-31 by Stone Paul A.
  • 4: filed on 2023-08-23 by Stone Paul A.
  • 4: filed on 2023-08-18 by Stone Paul A.
  • 4: filed on 2023-08-11 by THRONE JASON
  • 4: filed on 2023-08-11 by Stone Paul A.
  • 4: filed on 2023-07-12 by THRONE JASON

    • Events (8k)

  • 8-K: filed on 2023-11-17:
    Item 1.01: Entry into a Material Definitive Agreement
  • 8-K: filed on 2023-11-07:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-10-27:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-10-24:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
  • 8-K: filed on 2023-10-23:
    Item 8.01: Other Events
  • 8-K: filed on 2023-09-26:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-08-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-03:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-06-30:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-09:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events

    • Proposed Sales (Form 144)

  • 144: filed on 2023-05-22:
  • 144: filed on 2023-07-10:
  • 144: filed on 2023-08-09:
  • 144: filed on 2023-09-01:
  • 144: filed on 2023-11-27:
  • 144: filed on 2023-11-28:

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    5.2 Thousand total shares from 1 transactions

    Exercise Derivative Conversion (M)

    5.2 Thousand total shares from 1 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    THRONE JASON CHIEF LEGAL OFFICER

    • Officer
    		 0 2023-11-03 8

    RUIZ BRISENO ANDRES SEE REMARKS

    • Officer
    		 32,531 2023-09-01 2

    STONE PAUL A. CHIEF FINANCIAL OFFICER

    • Officer
    		 9,303 2023-08-29 6

    YARNO WENDY L

    • Director
    		 0 2023-06-07 1

    ROSEN TERRY J

    • Director
    		 0 2023-06-07 1

    SHANNON TIMOTHY M

    • Director
    		 0 2023-06-07 1

    STEIN JEFFREY

    • Director
    		 0 2023-06-07 1

    KELLEY SUSAN L.

    • Director
    		 0 2023-06-07 1

    MACKEY CATHERINE J

    • Director
    		 0 2023-06-07 1

    MORRISON SCOTT W

    • Director
    		 0 2023-06-07 1

    HAMPTON MALCOLM GARRET

    • Director
    		 0 2023-06-07 1

    HATA YUJIRO S PRESIDENT AND CEO

    • Officer
    • Director
    		 677,887 2023-04-12 2

    BEAUPRE DARRIN CHIEF MEDICAL OFFICER

    • Officer
    		 0 2023-02-24 2

    WHITE MICHAEL ANTHONY CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2023-02-24 1

    DILLON MICHAEL P. SVP, CHIEF SCIENTIFIC OFFICER

    • Officer
    		 102,226 2021-10-04 0

    LACKNER MARK SVP, HEAD OF BIOLOGY

    • Officer
    		 45,000 2021-02-24 0

    BVF PARTNERS L P/IL

    BIOTECHNOLOGY VALUE FUND L P

    BVF I GP LLC

    BIOTECHNOLOGY VALUE FUND II LP

    BVF II GP LLC

    BIOTECHNOLOGY VALUE TRADING FUND OS LP

    BVF PARTNERS OS LTD.

    BVF GP HOLDINGS LLC

    BVF INC/IL

    LAMPERT MARK N

    • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
    		 No longer subject to file 2021-02-02 0

    5AM VENTURES IV, L.P.

    5AM CO-INVESTORS IV, L.P.

    5AM PARTNERS IV, LLC

    5AM OPPORTUNITIES I, L.P.

    5AM OPPORTUNITIES I (GP), LLC

    DIEKMAN JOHN D

    SCHWAB ANDREW J.

    ROCKLAGE SCOTT M

    • 10% Owner
    • FORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDER
    		 No longer subject to file 2020-11-11 0

    HAMBLETON JULIE SVP, CHIEF MEDICAL OFFICER

    • Officer
    		 0 2020-02-21 0

    DIEKMAN JOHN D

    • Director
    		 0 2019-09-24 0

    HAGER JEFFREY SVP, CHIEF TECHNOLOGY OFFICER

    • Officer
    		 127,853 2019-07-26 0

    5AM VENTURES IV, L.P.

    5AM CO-INVESTORS IV, L.P.

    5AM PARTNERS IV, LLC

    ROCKLAGE SCOTT M

    SCHWAB ANDREW J.

    • 10% Owner
    		 3,463,066 2019-05-28 0

    CANAAN X L.P.

    CANAAN PARTNERS X LLC

    • 10% Owner
    		 2,660,713 2019-05-28 0

    ALEXANDRIA VENTURE INVESTMENTS, LLC

    • 10% Owner
    		 No longer subject to file 2019-05-28 0

    SCHROEDER THILO

    • Director
    		 0 2019-05-22 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    THRONE JASON - Officer CHIEF LEGAL OFFICER

    		2023-11-07 17:47:40 -0500 2023-11-03 M 5,163 $12.86 a 5,163 direct yes -4.9806 -4.075 0.0 1 -5.5627 4

    THRONE JASON - Officer CHIEF LEGAL OFFICER

    		2023-11-07 17:47:40 -0500 2023-11-03 S 5,163 $30.09 d 0 direct yes -4.9806 -4.075 0.0 1 -5.5627 4

    THRONE JASON - Officer CHIEF LEGAL OFFICER

    		2023-11-07 17:47:40 -0500 2023-11-03 M 5,163 d 48,750 direct yes

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    IDEAYA BIOSCIENCES INC IDYA 2023-11-28 22:15:04 UTC 5.07 0.25 1400000
    IDEAYA BIOSCIENCES INC IDYA 2023-11-28 21:45:03 UTC 5.07 0.25 1400000
    IDEAYA BIOSCIENCES INC IDYA 2023-11-28 21:15:04 UTC 5.07 0.25 1400000
    IDEAYA BIOSCIENCES INC IDYA 2023-11-28 20:45:04 UTC 5.07 0.25 1400000
    IDEAYA BIOSCIENCES INC IDYA 2023-11-28 20:15:04 UTC 5.07 0.25 1400000
    IDEAYA BIOSCIENCES INC IDYA 2023-11-28 19:45:03 UTC 5.07 0.25 1400000
    IDEAYA BIOSCIENCES INC IDYA 2023-11-28 19:15:04 UTC 5.07 0.25 1400000
    IDEAYA BIOSCIENCES INC IDYA 2023-11-28 18:45:03 UTC 5.07 0.25 1400000
    IDEAYA BIOSCIENCES INC IDYA 2023-11-28 18:15:03 UTC 5.07 0.25 1400000
    IDEAYA BIOSCIENCES INC IDYA 2023-11-28 17:45:04 UTC 5.07 0.25 1400000
    IDEAYA BIOSCIENCES INC IDYA 2023-11-28 17:15:04 UTC 5.07 0.25 1400000
    IDEAYA BIOSCIENCES INC IDYA 2023-11-28 16:45:04 UTC 5.07 0.25 1400000
    IDEAYA BIOSCIENCES INC IDYA 2023-11-28 16:15:04 UTC 5.07 0.25 1400000
    IDEAYA BIOSCIENCES INC IDYA 2023-11-28 15:45:03 UTC 5.0449 0.2751 1400000
    IDEAYA BIOSCIENCES INC IDYA 2023-11-28 15:15:03 UTC 5.0449 0.2751 1400000
    IDEAYA BIOSCIENCES INC IDYA 2023-11-28 14:45:04 UTC 5.0443 0.2757 1400000
    IDEAYA BIOSCIENCES INC IDYA 2023-11-28 14:15:04 UTC 5.0443 0.2757 1400000
    IDEAYA BIOSCIENCES INC IDYA 2023-11-28 13:45:04 UTC 5.0659 0.2541 1400000
    IDEAYA BIOSCIENCES INC IDYA 2023-11-28 13:15:03 UTC 5.0659 0.2541 1400000
    IDEAYA BIOSCIENCES INC IDYA 2023-11-28 12:45:04 UTC 5.0659 0.2541 1400000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments